Two Approaches to Triple Antithrombotic Therapy in Patients with Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Treated with Percutaneous Coronary Intervention: Which Is More Efficient and Safer?
Witold BachorskiJakub BychowskiMarcin GruchałaMiłosz JaguszewskiPublished in: Diagnostics (Basel, Switzerland) (2023)
Among patients with ACS and AF who had undergone PCI, there was no significant difference in the risk of bleeding and ischemic events among those who received TAT with NOAC and VKA.
Keyphrases
- atrial fibrillation
- percutaneous coronary intervention
- oral anticoagulants
- acute coronary syndrome
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- acute myocardial infarction
- antiplatelet therapy
- catheter ablation
- left atrial
- direct oral anticoagulants
- coronary artery bypass grafting
- left atrial appendage
- coronary artery disease
- heart failure
- coronary artery bypass
- stem cells
- oxidative stress
- cell therapy
- blood brain barrier
- newly diagnosed
- bone marrow
- smoking cessation